Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

Rhea-AI Summary

Alector, a clinical-stage biotech firm specializing in immuno-neurology, is set to host a virtual Research and Development event on June 18, 2024. The event will highlight the Alector Brain Carrier, a novel blood-brain barrier (BBB) technology platform. This platform is integral to the company’s upcoming product candidates and research initiatives. The session will feature insights from Alector's management and Dr. Zhiqiang An, an expert in BBB modulation. Participants can register on Alector's website, and a live Q&A will follow the presentation. A replay will be accessible for 90 days post-event.

Positive

• Alector is advancing its proprietary BBB technology platform, potentially enhancing its product pipeline.
• Involvement of a distinguished expert, Dr. Zhiqiang An, underscores the credibility and scientific rigor of the event.
• The virtual event offers transparency and direct communication with investors and stakeholders.
• A live Q&A session promotes engagement and provides real-time feedback.

Negative

• No specific financial data or new clinical trial results were announced in the press release.
• The impact of the BBB technology on stock performance remains speculative until further data is provided.
• Relying on a virtual event may limit engagement compared to in-person meetings.

Leading scientific expert to provide insights into emerging technologies for blood-brain barrier modulation

SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB) technology platform that is being applied selectively to the Company’s next-generation product candidates and research pipeline. The event will include a presentation from Alector’s management team as well as a leading scientific expert who will offer insights into emerging technologies for BBB modulation and discuss future directions and opportunities in the field.

Details of the webinar are as follows:

Crossing the Blood-Brain Barrier: Advancing the Next Generation of Alector Neurodegenerative Therapies

June 18, 2024, from 3:00 pm - 4:30 pm Eastern Daylight Time (EDT)

Alector’s management team will be joined by:

• Zhiqiang An, Ph.D., Professor & Robert A. Welch Distinguished University Chair in Chemistry and Director of the Texas Therapeutics Institute at UTHealth Houston
  

A live question and answer session will follow the formal presentation. To access the live webcast of this event, please register here, or visit “Events and Presentations” in the “Investors” section of the Alector website at https://investors.alector.com. An archived replay will be available for approximately 90 days following the presentation.

About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and seek to treat indications, including Alzheimer’s disease and genetically defined frontotemporal dementia patient populations. Alector is headquartered in South San Francisco, California.

Alector Contacts:

Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com

1AB (media)
Dan Budwick
973-271-6085 
dan@1abmedia.com

Argot Partners (investors)
Laura Perry
212.600.1902
alector@argotpartners.com

FAQ

What is the date and time of Alector's virtual R&D event?

The event will take place on June 18, 2024, from 3:00 pm to 4:30 pm EDT.

What is Alector Brain Carrier?

Alector Brain Carrier is a proprietary blood-brain barrier technology platform applied to Alector's next-generation product candidates and research pipeline.

Who is the expert speaking at Alector's event?

Dr. Zhiqiang An, a Professor and Director at UTHealth Houston, will provide insights during the event.

How can I access the live webcast of Alector's event?

You can register via Alector's website under the 'Events and Presentations' section in the 'Investors' area.

Will there be a replay available for Alector's virtual event?

Yes, an archived replay will be available for approximately 90 days following the presentation.